Overview
PathAI provides integrated AI and digital pathology solutions that analyze whole-slide images to detect patterns, quantify biomarkers, and support more accurate, reproducible diagnoses. Its AISight platform serves as a central hub for case and image management, AI applications, and lab workflows, supporting both clinical diagnostics and biopharma R&D.
Pricing
Enterprise / Lab Deployments
- PathAI uses custom enterprise pricing; public advisors describe it as a premium solution priced for hospitals, large pathology labs, and biopharma companies.
- Contracts typically consider factors like number of scanners and sites, slide volumes, use cases (clinical vs. research), and integrations with LIS/EMR systems.
Per-Site / Per-Use Models
- Deals often follow a per-site license or usage-based pricing tied to slide volumes and AI applications (e.g., specific biomarkers or companion diagnostic assays).
- Biopharma projects are frequently structured as separate service engagements for clinical trials and biomarker programs.
Target Customers
- Primary customers are academic medical centers, reference labs, integrated delivery networks, and biopharma companies running clinical trials.
- Not positioned as a low-cost tool for small private labs; pricing reflects enterprise-grade deployments.
Key Features
- AISight digital pathology platform – Image management system that centralizes cases, slides, and AI apps, enabling multiple histopathology use cases.
- AI-powered slide analysis – Deep-learning models trained on millions of pathologist-annotated images to detect cancer, classify tissue, and quantify features.
- Biomarker quantification – Automated scoring of biomarkers such as PD‑L1 and HER2, supporting more consistent and objective readouts.
- Biopharma & clinical trial solutions – Services and tools for patient stratification, endpoint assessment, and companion diagnostic development.
- Precision Pathology Network – Network of partner labs using AISight and PathAI models, enabling large-scale, real-world data and standardized workflows.
Best Use Cases
- Oncology diagnostics – Support for cancer diagnosis, grading, and biomarker scoring to guide therapy decisions.
- Biopharma clinical trials – Central review, consistent biomarker quantification, and AI-enhanced endpoints for drug development.
- Digital transformation of pathology labs – Transition from glass to digital workflows with integrated AI triage and QA.
- Research & biomarker discovery – Large-scale image analysis to discover new histologic features linked to outcomes and response.
- Networked precision pathology – Multi-site health systems and networks seeking standardized, AI-augmented pathology.
Pros
- ✅ Deep pathology specialization – Purpose-built for histopathology, trained on massive, expertly annotated slide datasets.
- ✅ Improved accuracy & consistency – AI models help reduce variability and provide objective, reproducible measurements.
- ✅ Strong biopharma partnerships – Widely used in drug development, accelerating biomarker programs and trial readouts.
- ✅ End-to-end digital pathology stack – AISight, AI models, services, and a lab network provide a comprehensive solution.
Cons
- ❌ Enterprise-only pricing – High, quote-based pricing puts PathAI out of reach for small labs and solo practices.
- ❌ Implementation complexity – Requires digital scanners, storage, integrations, and change management to realize full value.
- ❌ Highly specialized scope – Focused on pathology; not a general-purpose AI tool for broader hospital IT needs.
Official Website
PathAI – Official website and AISight platform: https://www.pathai.com
Release Date: Founded in 2016 by Andy Beck and Aditya Khosla.
Last Updated: December 2025